scholarly journals Dosing to rash: A phase II trial of the first-line erlotinib for patients with advanced non-small-cell lung cancer an Eastern Cooperative Oncology Group Study (E3503)

2014 ◽  
Vol 50 (2) ◽  
pp. 302-308 ◽  
Author(s):  
J.R. Brahmer ◽  
J.W. Lee ◽  
A.M. Traynor ◽  
M.M. Hidalgo ◽  
J.M. Kolesar ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Eastern Cooperative Oncology Group ◽  
Small Cell ◽  
Oncology Group ◽  
Small Cell Lung ◽  
First Line ◽  
Oncology Group Study

A Phase II trial of carboplatin and vindesine in patients with non-small cell lung cancer. A Hellenic Cooperative Oncology Group study

Lung Cancer ◽  
1993 ◽  
Vol 10 (1-2) ◽  
pp. 85-89
Author(s):  
Nicholas A. Pavlidis ◽  
George Klouvas ◽  
Costas Nicolaides ◽  
Apostolos Karantanas ◽  
Marios Beer ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Oncology Group ◽  
Small Cell Lung ◽  
Oncology Group Study
Sign in / Sign up

Export Citation Format

Share Document